LifeMD, Inc. (LFMD)
Nasdaq · Healthcare · Health Information Services
$2.72−0.73%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $131M
- Forward P/E
- 7.2
- 52-week range
- $2.56 – $7.12
- 52-week change
- −60.52%
- EPS (trailing)
- −$0.51
- Next earnings
- Nov 9, 2026
Fiscal year to Dec 2025
- Revenue
- $194M (+25.35%)
- Net income
- −$11.2M
- Operating margin
- −4.0%
- Diluted EPS
- $0.25
- Free cash flow
- $6.4M
From the company’s annual report on SEC EDGAR.
About LifeMD, Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc.
Headquarters: New York, United States · 347 employees · lifemd.com